NCT06481826 2026-03-27
Glofitamab in Chinese Patients With R/R DLBCL
Peking Union Medical College Hospital
Recruiting
Clinical Trials
6 trialsNCT07472621 2026-03-16
Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
Henan Cancer Hospital
Not yet recruiting
NCT06985576 2025-12-18
Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
Not yet recruiting
NCT06592846 2025-07-22
FERTILE
The Lymphoma Academic Research Organisation
Completed
NCT07057765 2025-07-10
Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
Ain Shams University
Recruiting
NCT05377307 2025-05-13
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Pell Bio-Med Technology Co., Ltd.
Recruiting